CST4 and chronic kidney disease: Accordingly, UKBB CNV, and chiefly deletion carrier individuals, have increased levels of the renal biomarker cystatin C64,75,77 and were at increased risk for both chronic kidney disease (CKD) and acute kidney injury (AKI).76